DIABETES Interleukin-21 Receptor-Mediated Signals Control Autoreactive T Cell Infiltration in Pancreatic Islets Investigators concluded that interleukin-21 receptor controls both antigen transport by dendritic cells and the crucial beacon function of CD4+ cells for autoreactive CD8+ cells to reach the islets. [Immunity] Abstract ChREBP Mediates Glucose-Stimulated Pancreatic β-Cell Proliferation Researchers tested the hypothesis that carbohydrate response element-binding protein (ChREBP) is required for glucose-stimulated β-cell proliferation. [Diabetes] Abstract Inhibition of Gelatinase B (Matrix Metalloprotease-9) Activity Reduces Cellular Inflammation and Restores Function of Transplanted Pancreatic Islets Results indicate that the increase of matrix metalloprotease (MMP)-9 expression and activity after islet transplantation is directly related to enhanced leukocyte migration and that early islet graft survival can be improved by inhibiting MMP-9 activity. [Diabetes] Abstract Critical Role of c-Kit in Beta Cell Function: Increased Insulin Secretion and Protection Against Diabetes in a Mouse Model Findings demonstrate that c-Kit plays a direct protective role in beta cells, by regulating glucose metabolism and beta cell function. [Diabetologia] Abstract Mixed Chimerism and Growth Factors Augment ß Cell Regeneration and Reverse Late-Stage Type 1 Diabetes Researchers showed that combination therapy of induced mixed chimerism under a radiation-free nontoxic anti-CD3/CD8 conditioning regimen and administration of gastrin/epidermal growth factor augments both ß cell neogenesis and replication, resulting in reversal of late-stage type 1 diabetes in nonobese diabetic mice. [Sci Transl Med] Abstract | Press Release PANCREATIC CANCER KRas Induces a Src/PEAK1/ErbB2 Kinase Amplification Loop that Drives Metastatic Growth and Therapy Resistance in Pancreatic Cancer Researchers report that the novel tyrosine kinase PEAK1 is upregulated in human malignancies, including human pancreatic ductal adenocarcinomas (PDACs) and pancreatic intraepithelial neoplasia. Findings suggest that PEAK1 is a novel biomarker, critical signaling hub, and new therapeutic target in PDACs. [Cancer Res] Abstract | Press Release The MUC4 Mucin Mediates Gemcitabine Resistance of Human Pancreatic Cancer Cells via the Concentrative Nucleoside Transporter Family This work describes a new mechanism of pancreatic cancer cell resistance to gemcitabine, in which the MUC4 mucin negatively regulates the concentrative nucleoside transporter 1 transporter expression via the NF-κB pathway. [Oncogene] Abstract Pancreatic Cancer Therapy by Systemic Administration of VEGF siRNA Contained in Calcium Phosphate/Charge-Conversional Polymer Hybrid Nanoparticles Systemic administration of the smart polymer/calcium phosphate/small interfering RNA (siRNA) hybrid nanoparticles carrying vascular endothelium growth factor (VEGF) siRNA led to the significant reduction in the subcutaneous pancreatic cancer cell tumor growth, consistent with the enhanced accumulation of siRNA and the significant VEGF gene silencing in the tumor. [J Control Release] Abstract Loss of ATRX or DAXX Expression and Concomitant Acquisition of the Alternative Lengthening of Telomeres Phenotype Are Late Events in a Small Subset of MEN-1 Syndrome Pancreatic Neuroendocrine Tumors Findings establish the existence of ATRX (alpha thalassemia/mental retardation X-linked) and DAXX (death domain-associated protein) defects and the alternative lengthening of telomeres phenotype in pancreatic neuroendocrine tumors in the context of multiple endocrine neoplasia-1 (MEN-1) syndrome. [Mod Pathol] Abstract Triptolide Triggers the Apoptosis of Pancreatic Cancer Cells via the Downregulation of Decoy Receptor 3 Expression Researchers examined the antitumor effects of triptolide against pancreatic cancer and investigated the underlying mechanism. [J Cancer Res Clin Oncol] Abstract |